Minerva Neurosciences Inc (NERV)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $114.62M
Last updated: Nov 17, 2026 at 11:06 AM ET
Performance (10Y)
Upcoming Estimates
Key Metrics
Technical Indicators Dashboard
As of Nov 16, 2026, the price is 25.8% below its 50-day moving average, and the 50-day average is below the 200-day average. The 14-day RSI is 37.8, in the neutral range between 30 and 70.
Moving Averages
MACD
ADX
Aroon & PSAR
Bollinger Bands
RSI (14-Day)
Momentum Oscillators
Volatility Measures
Volume Flow
Volume Metrics
Pivot Points
Advanced Oscillators
Financial Performance
Related GNG Research
No research available
Be the first to write about NERV
GNG News
All NERV news- NERVJefferies raises Minerva Neurosciences (NERV) rating to Buy
UpdatedHistorical
News
NERV Valuation
Minerva Neurosciences (NERV) trades at 11.2x forward earnings.
- Forward P/E
- 11.2x
- P/B
- -1.1x
NERV Profitability: Margins, ROIC and FCF
Minerva Neurosciences (NERV) has an operating margin of 0.0% and a net margin of 0.0%.
- Operating margin
- 0.0%
- Net margin
- 0.0%
- ROE
- -675.0%
Minerva Neurosciences Competitors
The companies most similar to Minerva Neurosciences (NERV) include Neumora Therapeutics, NRX Pharmaceuticals and LENZ Therapeutics.
Sector: Healthcare
Companies most similar to Minerva NeurosciencesNERV Analyst Ratings
Minerva Neurosciences (NERV) has a Buy consensus from 3 analysts: 2 Buy or Strong Buy, 1 Hold and 0 Sell or Strong Sell.
- Consensus
- Buy
- Analysts
- 3
- Strong Buy
- 1
- Buy
- 1
- Hold
- 1
- Sell
- 0
- Strong Sell
- 0
NERV Earnings: Beat Rate and Next Report
Minerva Neurosciences (NERV) beat the EPS estimate in 5 of the 8 most recent quarters that had an estimate (62.5%). Its next report is expected on Mar 9, 2027.
- Beat rate
- 5 of 8 quarters (62.5%)
- Average surprise
- 64.2%
- EPS estimate (fiscal period ending Dec 31, 2026)
- -$0.14
NERV Earnings Date
NERV reports Mar 9, 2027. The date is estimated.
NERV ETF Holders
GNG tracks 2 ETFs that hold NERV. The largest weights:
- Vanguard Total Stock Market Index Fund Admiral Shares (VTSAX), <0.01% of the fund
- Vanguard Extended Market Index Fund ETF Shares (VXF), <0.01% of the fund
Updated Nov 6, 2026. Built from end-of-day prices, company filings and consensus analyst estimates. Methodology
Frequently Asked Questions About NERV
When does NERV report earnings?
Minerva Neurosciences Inc (NERV) is expected to report earnings on Mar 9, 2027.
Does NERV pay dividends?
Minerva Neurosciences Inc (NERV) does not currently pay a regular dividend.
What is NERV's market cap?
Minerva Neurosciences Inc (NERV) has a market capitalization of $114.62M with a current stock price of $2.20.
NERV pages: Overview, Earnings, Forecast, Financials, Competitors
Get full access to GNG Research
Create a free account to access portfolio tracking, advanced tools, and more.